These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Differences between COX-2-specific inhibitors: clinical and economic implications. Sonnenblick EH Am J Manag Care; 2002 Oct; 8(15 Suppl):S428-30. PubMed ID: 12416792 [No Abstract] [Full Text] [Related]
6. Merck withdraws arthritis drug worldwide. Singh D BMJ; 2004 Oct; 329(7470):816. PubMed ID: 15472245 [No Abstract] [Full Text] [Related]
7. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs. Atkinson HG Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146 [No Abstract] [Full Text] [Related]
8. [Thinking about the specific cyclooxygenase-2 inhibitors since its recommendation]. Shi G Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):579-80. PubMed ID: 11758234 [No Abstract] [Full Text] [Related]
9. [New study of selective COX-2 inhibitors. Protecting the stomach while risking the heart? (interview by Dr. Beate Schumacher)]. Zeidler H MMW Fortschr Med; 2001 Sep; 143(35-36):14. PubMed ID: 11584521 [No Abstract] [Full Text] [Related]
11. Market withdrawal of Vioxx: is it time to rethink the use of COX-2 inhibitors? Ortiz E J Manag Care Pharm; 2004; 10(6):551-4. PubMed ID: 15548128 [TBL] [Abstract][Full Text] [Related]
12. The coxibs, selective inhibitors of cyclooxygenase-2. FitzGerald GA; Patrono C N Engl J Med; 2001 Aug; 345(6):433-42. PubMed ID: 11496855 [No Abstract] [Full Text] [Related]
13. [No loss of effectiveness with rofecoxib. Long-term control of rheumatoid pain]. Einecke D MMW Fortschr Med; 2002 Nov; 144(46):68. PubMed ID: 12534087 [No Abstract] [Full Text] [Related]
14. [New anti-inflammatory analgetics--are they needed?]. Paakkari I Duodecim; 1999; 115(20):2217-24. PubMed ID: 11973925 [No Abstract] [Full Text] [Related]
15. Cardiovascular complications of COX2 selective inhibitors cause considerable concern. Hedner T; Himmelmann A Blood Press; 2004; 13(5):260-1. PubMed ID: 15545147 [No Abstract] [Full Text] [Related]
16. The coxibs, selective inhibitors of cyclooxygenase-2. Killen JP N Engl J Med; 2001 Dec; 345(23):1708; author reply 1709. PubMed ID: 11759656 [No Abstract] [Full Text] [Related]
17. COX-2 inhibitors--a lesson in unexpected problems. Drazen JM N Engl J Med; 2005 Mar; 352(11):1131-2. PubMed ID: 15713947 [No Abstract] [Full Text] [Related]
18. Wolf in sheep's clothing? Varga J Am J Hosp Palliat Care; 2000; 17(4):280. PubMed ID: 11883807 [No Abstract] [Full Text] [Related]
19. COX-2 inhibitors--lessons in drug safety. Psaty BM; Furberg CD N Engl J Med; 2005 Mar; 352(11):1133-5. PubMed ID: 15713946 [No Abstract] [Full Text] [Related]
20. MI risk prompts rofecoxib withdrawal. Thompson CA Am J Health Syst Pharm; 2004 Nov; 61(21):2234-6, 2238. PubMed ID: 15552625 [No Abstract] [Full Text] [Related] [Next] [New Search]